Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06373471 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment

Study acronym: IMPROVE
StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 18, 2024 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Apr 2024); last known: Recruiting
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Improve study is a randomized controlled trial investigating the efficacy of adding comprehensive geriatric assessment and treatment to standard of care compared with standard of care in older, frail patients with hematological cancer. The investigators aim to recruit 152 study participants who will be randomized 1:1 to intervention- or control group. Study participants in the intervention group will receive the intervention comprehensive geriatric assessment and treatment integrated in the cancer treatment. Study participants in the control group will receive cancer treatment and evaluation of comorbidity and frailty as is usual standard at Department of Hematology. Primary endpoint is elderly functional Index at 12 weeks.
Trial Details
NCT Number NCT06373471
Lead Sponsor Odense University Hospital
Collaborators: Velux Fonden, Danish Cancer Research Foundation, The Dagmar Marshall Foundation
Conditions
(from sponsor)		 Hematologic Malignancy, Treatment Adherence, Treatment Complication, Frailty, Quality of Life
Related terms Frailty, Hematologic Neoplasms, Treatment Adherence and Compliance
Enrollment 152 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov